Literature DB >> 21765697

The ochsner experience with acute lymphoblastic leukemia in childhood.

M A Schorin1, R S Ducos.   

Abstract

Pediatricians at Ochsner Clinic and Alton Ochsner Medical Foundation have treated children with acute lymphoblastic leukemia for the past 17 years with excellent results. Although a single institution, and small in comparison to the national cooperative groups, we have achieved results comparable to the most successful national groups. In collaboration with the Dana-Farber Cancer Institute in Boston, MA, we have pursued several themes of study, including the comparison of various drugs, doses, and schedules of administration in the context of an investigational window in previously untreated patients. Schedules and dosages of radiation for prevention of relapse of leukemia in the central nervous system have also been studied with interesting results.

Entities:  

Year:  2000        PMID: 21765697      PMCID: PMC3117505     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  17 in total

1.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

Authors:  D H Mahoney; J J Shuster; R Nitschke; S J Lauer; C P Steuber; N Winick; B Camitta
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

2.  Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia.

Authors:  S A Atkinson; L Fraher; C M Gundberg; M Andrew; M Pai; R D Barr
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

3.  Toxicity of CNS prophylaxis for childhood leukemia.

Authors:  Deborah P Waber; Nancy J Tarbell
Journal:  Oncology (Williston Park)       Date:  1997-02       Impact factor: 2.990

4.  Comparative pharmacokinetic studies of three asparaginase preparations.

Authors:  B L Asselin; J C Whitin; D J Coppola; I P Rupp; S E Sallan; H J Cohen
Journal:  J Clin Oncol       Date:  1993-09       Impact factor: 44.544

5.  Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

Authors:  M A Schorin; S Blattner; R D Gelber; N J Tarbell; M Donnelly; V Dalton; H J Cohen; S E Sallan
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

6.  Intellectual performance after presymptomatic cranial radiotherapy for leukaemia: effects of age and sex.

Authors:  D Christie; A D Leiper; J M Chessells; F Vargha-Khadem
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

7.  Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

Authors:  M Smith; D Arthur; B Camitta; A J Carroll; W Crist; P Gaynon; R Gelber; N Heerema; E L Korn; M Link; S Murphy; C H Pui; J Pullen; G Reamon; S E Sallan; H Sather; J Shuster; R Simon; M Trigg; D Tubergen; F Uckun; R Ungerleider
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

8.  Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.

Authors:  B Camitta; B Leventhal; S Lauer; J J Shuster; S Adair; J Casper; C Civin; M Graham; D Mahoney; L Munoz
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

9.  Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

Authors:  L A Clavell; R D Gelber; H J Cohen; S Hitchcock-Bryan; J R Cassady; N J Tarbell; S R Blattner; R Tantravahi; P Leavitt; S E Sallan
Journal:  N Engl J Med       Date:  1986-09-11       Impact factor: 91.245

10.  Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia.

Authors:  E Smibert; V Anderson; T Godber; H Ekert
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more
  1 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2001-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.